Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/26/2767536/0/en/eGenesis-Presents-Preclinical-Data-Demonstrating-Recipient-Survival-and-Compatibility-with-Genetically-Engineered-Porcine-Kidneys-at-2023-IPITA-IXA-CTRMS-Joint-Conference.html
https://www.globenewswire.com//news-release/2023/10/11/2758584/0/en/eGenesis-Announces-Publication-in-Nature-of-Landmark-Preclinical-Data-Demonstrating-Long-Term-Survival-with-Genetically-Engineered-Porcine-Kidneys.html
https://endpts.com/egenesis-brings-xenotransplants-closer-to-the-clinic/
https://www.globenewswire.com/news-release/2023/06/13/2686913/0/en/eGenesis-Announces-Publication-in-Nature-Communications-Characterizing-Renal-Physiology-and-Endocrine-Function-in-Non-Human-Primates-Post-Xenograft-Transplant.html
https://www.globenewswire.com/news-release/2023/06/05/2681953/0/en/eGenesis-Presents-New-Data-on-Long-Term-Survival-in-Preclinical-Kidney-Xenotransplantation-at-American-Transplant-Congress-2023.html
https://www.globenewswire.com/news-release/2023/01/24/2594206/0/en/eGenesis-Announces-Knut-Niss-as-Chief-Technology-Officer.html
https://www.globenewswire.com/news-release/2023/01/09/2585250/0/en/eGenesis-and-Eledon-Pharmaceuticals-Announce-Collaboration-for-Use-of-Tegoprubart-in-Preclinical-Xenotransplantation-Studies.html
https://endpts.com/former-egenesis-ceo-joins-vtv-as-it-tries-to-make-a-comeback-eisai-nabs-alzheimers-commercial-exec-amid-lecanemab-push/